Molecular Properties Prediction, Docking Studies, and Antimicrobial Screening of 1,3,4-Thiadiazole and s-Triazole Derivatives

Author(s): Agata Siwek, Tomasz Plech, Joanna Stefanska, Pawel Staczek, Aleksandra Strzelczyk

Journal Name: Current Computer-Aided Drug Design

Volume 10 , Issue 1 , 2014

Become EABM
Become Reviewer


A series of 1,3,4-thiadiazoles and s-triazoles were subjected to Molinspiration, ALOGPS 2.1, and Osiris programs to predict their molecular properties that are important for drug candidates. Subsequently, all of them were docked into the active sites of enzymes namely glucosamine-6-phosphate synthase (GlcN-6-P), VIM-2 metallo-β- lactamase (VIM-2), chitinase A1 (ChiA1), and sterol 14 alpha-demethylase (CYP51) that were considered in antimicrobial studies of thiadiazole and s-triazole derivatives. Since all compounds fulfilled the criteria for good membrane permeability, oral bioavailability, low toxicity and the potential inhibitory activities towards VIM-2, ChiA1, and CYP51, most of them were synthesized and their antimicrobial activity has been tested.

Keywords: Antibacterial action, antifungal action, molecular docking, molecular properties prediction, 1, 3, 4-thiadiazole, striazole.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [3 - 14]
Pages: 12
DOI: 10.2174/15734099113096660033
Price: $65

Article Metrics

PDF: 36